Working with Scientia Advisors

---

Scientia Advisors Leaders

---

What Our Clients Are Saying

---

Case Studies

---

Scientia Advisors Brochure

---

Large healthcare products firm pursues regenerative medicine

Helping a healthcare products leader enter a new market

Our Client's Challenge

Our client, a global healthcare products leader, sought long-term sustainable growth opportunities emerging within 5-10+ years in the field of regenerative medicine. The challenge, therefore, was:

Should we enter the regenerative medicine market and, if so, what steps should we take?

Management required an in-depth understanding of the regenerative medicine market with a detailed roadmap for capturing the identified segment(s).

Scientia Advisors' Approach

Scientia Advisors performed a detailed analysis of the regenerative medicine market and deployed a team of consultants to conduct interviews, internally with employees and externally with orthopedic, neurology, gastroenterology, endocrinology, and cardiovascular experts. We collected data to assess requirements for success and benchmark major competitors. Ultimately, Scientia Advisors:

• Identified seven attractive regenerative medicine market segments
• Characterized viable business models along the regenerative medicine value chain
• Prepared a partnering and acquisition shortlist of companies

The Results

Our team performed a robust assessment of regenerative medicine pipeline products and prioritized opportunities where the client could initiate investments and involvement into future growth markets relevant to their present core businesses. The client received:

• A blueprint for what segments to target
• An initial plan for market entry

The client was more than satisfied with Scientia Advisors' final plan for entry and utilized our services for future engagements.